Your browser doesn't support javascript.
loading
Drug Resistance Profile Among HIV-1 Infections Experiencing ART with Low-Level Viral Load in Guangdong China During 2011-2022: A Retrospective Study.
Lan, Yun; Ling, Xuemei; Deng, Xizi; Lin, Yaqing; Li, Junbin; Li, Liya; He, Ruiying; Cai, Weiping; Li, Feng; Li, Linghua; Hu, Fengyu.
Afiliação
  • Lan Y; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510440, People's Republic of China.
  • Ling X; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510440, People's Republic of China.
  • Deng X; Guangdong Center for Diagnosis and Treatment of AIDS, Guangzhou, 510060, People's Republic of China.
  • Lin Y; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510440, People's Republic of China.
  • Li J; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510440, People's Republic of China.
  • Li L; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510440, People's Republic of China.
  • He R; Guangdong Center for Diagnosis and Treatment of AIDS, Guangzhou, 510060, People's Republic of China.
  • Cai W; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510440, People's Republic of China.
  • Li F; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510440, People's Republic of China.
  • Li L; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510440, People's Republic of China.
  • Hu F; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510440, People's Republic of China.
Infect Drug Resist ; 16: 4953-4964, 2023.
Article em En | MEDLINE | ID: mdl-37546367
ABSTRACT

Background:

Antiretroviral therapy (ART) efficiently reduces the morbidities and mortalities caused by HIV-1 infection and prevents the HIV epidemic. However, virologic failure (VF) occurs in some patients receiving ART experience, especially increases in those patients with intermittent or persistent low-level viremia (LLV). The presence of drug resistance mutations (DRMs) in LLV was a strong predictor of subsequent VF. The data on drug resistance (DR) or DRMs for HIV-1 infections at low-level viral load (LLVL) are limited in China.

Objective:

To monitor the prevalence of HIV-1 drug resistance and to evaluate the risk factors associated with drug resistance in LLVL HIV-1 infections during ART in Guangdong, China.

Methods:

Plasma samples with LLVL during ART in Guangdong Province between Jan 2011 and Dec 2022 were subjected to a modified reverse-transcription PCR with a pre-step of virus concentration by ultracentrifugation before extraction and the Sanger sequencing. Then, the genotypic resistance test was performed and DR was analyzed by the Stanford HIVDB program. Finally, DR-associated factors were identified by logistic regression analysis.

Results:

We found that CRF01_AE (53.57%) and CRF07_BC (25.07%) were the dominant HIV-1 genotypes in LLVL in Guangdong between 2011 and 2022 but that the percentage of CRF01_AE showed a trend of decrease over time. M46 (1.49%), M184 (30.91%), and K103 (21.46%) were the dominant PI-, NRTI-, and NNRTI-associated mutations, respectively. The total DR rate was 47.06%. Specifically, PI (3.71%) showed a significantly lower DR rate than NNRTI (40.74%) and NRTI (34.14%). Duration of ART, initial ART regimen, ethnicity, and WHO clinical stages were associated with DR.

Conclusion:

The drug resistance rate among the LLVL during ART in Guangdong, China is high. The risk factors associated with HIV drug resistance should be seriously considered for better control.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article